Figure 4.
Outcomes in MRD– patients. (A) Multivariable competing risk regression of factors associated with relapse (left) and Cox regression for OS (right) in MRD– patients. The HR for age is per 10 years, and WCC and platelets were log-transformed. (B) Kaplan-Meier curves of OS by FLT3-ITD for all patients (left), MRD– patients (middle), and MRD-positive patients (right). ∗Cytogenetic risk is with normal karyotype as the reference group. ^NPM1 mutation type is with type A as the reference group.

Outcomes in MRD patients. (A) Multivariable competing risk regression of factors associated with relapse (left) and Cox regression for OS (right) in MRD patients. The HR for age is per 10 years, and WCC and platelets were log-transformed. (B) Kaplan-Meier curves of OS by FLT3-ITD for all patients (left), MRD patients (middle), and MRD-positive patients (right). ∗Cytogenetic risk is with normal karyotype as the reference group. ^NPM1 mutation type is with type A as the reference group.

or Create an Account

Close Modal
Close Modal